Selected List of InterLink Assignments

• Advance Technologies (Cambridge), Ltd (UK): Technology Assessment and Research & Development Strategy

• ASA Pharma PLC (Ireland): Identify development and marketing partners in North America

• BASF (Germany): Development of a Biotechnology Strategy for applications in the biotechnology seed business

• Biofrutales S.A. (Chile): Technology Assessment and strategy recoomendations

• BioMan S.r.l (Italy): Out-license key technology in North America

• Cerylid Biosciences Ltd (Australia): Divestiture of key technology assets

• Chile-Global (Chile): Technology assessment and technology brokerage

• CONICYT (Chile): Consulting services: Technology evaluation

• Consejo Nacional de Innovacion (National Council for Innovation). Santiago, Chile:

  1. National Biotechnology Assessment and Strategic Recommendations
  2. Establishment of Centers for Innovation Technology Transfer and Entrepreneurship (CITE) in Chile

• Dekalb Genetics: Technology assessment/due diligence in the acquisition of BioTechnica International Inc. Sale a portion of seed business assets

• Fundacion Chile (Chile): Consulting services: Biotechnology strategy

• GenVitis S.A. (Chile) Created new company involved in grape biotechnology.

• ENI-Euron (Italy): Biotechnology strategy for biofuels and biolubricants

• Fondazione Istituto Insubrico di Ricerca per la Vida (Italy) Provide access to natural product libraries and microbial collection for pharmaceutical and biotechnology industries.

• FemtoLink Biotechnologies LLC: Sale of BSE Prion Detection Patent Portfolio to ISTA/DOMPE S.p.A. Milan, Italy

• GAVISH Ltd. Galilee Bio Applications Ltd (Galilee Technology Center. Israel): Identify partners for product development and marketing in the fields of post-harvest technology and miniature, portable and automated DNA analysis device (SENSIS Ltd.)

• Immunovative Therapeutics, Inc. (Israel): Identify source of capital from private investors and strategic and marketing partners

• InGene Inc. (Taiwan): Assistance in obtaining FDA approval to produce transgenic enzyme as a feed additive in the USA

• Institute for Hepatitis and Virus Research: Consulting in the field of Natural Products Libraries

• Interlink Biotechnologies (Auburn, CA):
  
  1. Sale of Peptides Patent Portfolio to VDDI Pharmaceuticals Inc. (Brentwood, TN)

  2. Sale of Microbial Collection to Smithkline Beecham (Madrid, Spain). 

  3. Sale of Fungal Collection to Schering Plough (Kenilworth, NJ)

  4. Sale of Microbial Collection to Cetek Inc. (Marlborough, MA)

  5. Sale of Microbial Collection to Wyeth-Fort Dodge (Princeton, NJ)

  6. Provide access to microbial insecticidal proteins to Dow AgroSciences.

  7. Provide access to microbial extracts as a source of new drugs to Novo Nordisk (Denmark).

• Interlink Biotechnologies (Princeton, NJ): Sale of the company assets to Abraxis Biosciences (Nasdaq: ABII) a US based pharmaceutical company

• IVS ISTA (Italy):
  
  - Identify partners for corn, soybean, rice, barley breeding and marketing in the US and Italy.
  - Identify new product opportunities to the parent company (Adraitica S.p.a)

• Limagrain Group (France):

  - Strategic planning of technology and development of a comprehensive strategy for applications of biotechnology in Limagrain's seed and molecular farming business.

  - On behalf of Limagrain, approached US second largest seed company as an acquisition target.

• Lucien Biotechnologies (Chile): Identify partners for technology development and marketing

• MedSonics Inc: Identify source of capital from private investors and strategic partners

• Mycosynthetix Inc: Divestiture of key technology assets

• Montedison Group (Italy): Biotechnology Research and Development strategy for the sugar beet industry in the USA

• Multi-Client Study (Several pharmaceutical and biotechnology companies): World-Wide Resources for Bimolecular Screening

• NAICOS (New Anti-infective Consortium) (Italy): Provide access to microbial library for pharmaceutical and biotechnology industries.

• Nascent Pharmaceuticals: Identify source of capital from private investors and strategic and marketing partners

• Nissan Chemicals (Japan): Performed a technical and market assessment of new biocides and anti-biofilm agents

• Novartis (Switzerland): Acquisition of AgriTrading (Milan, Italy)

• Nuskin (Pharmanex): Established capabilities in South America for the production of a nutraceutical

• Ohr Pharmaceuticals: Divestiture of key technology assets

• Parco Tecnologico Padano: (Italy) Technology Assessment and marketing of patent portfolio

• Pharmacopia: Performed a technical and marketing assessment of the role of combinatorial libraries in the development of new agricultural chemicals.

• PhenoGenomics Corporation: Divestiture of key technology assets and identify strategic and development partners

• Phytomedics Chile S.A. (Chile) participated in the creation of a new company in the field of nutraceuticals in alliance with Phytomedics Inc. (USA), Rutgers University, University of Illinois and Fundacion Chile (Santiago, Chile).

• Provid Pharmaceuticals Inc: Identify source of capital from private investors and strategic and marketing partners

• Philip Morris Europe (Switzerland): Biotechnology Database

• PhytoPharmacon, Inc: Divestiture of key technology assets.

• Sumitomo Chemicals-Valent USA: Comprehensive study to assess the effect of transgenic crops in the company's agricultural chemical business. Strategic recommendation

• Vitis Biosciences Inc: Created new company involved in grape biotechnology.

• Yaupon Therapeutics Inc: Identify source of capital from private investors and strategic and marketing partners

Take the guesswork out of your technology strategy. Contact InterLink to get started.

© Copyright 2009 by Interlink Associates, LLC.